The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vicky Shah

Mr. Vicky Shah, who is not part of the promoter/promoter group, acquired 20,75,000 equity shares (14.46%) of Bacil Pharma Ltd through an off-market deal on 19 February 2026. His holding jumped from 3,06,695 shares (2.14%) to 23,81,695 shares (16.60%) of the company's paid-up equity capital (1,43,53,000 shares of Rs. 10 each). This filing is the mandatory disclosure under SEBI's Substantial Acquisition of Shares & Takeovers rules, triggered because the acquisition crossed the 5%, 10%, and 15% disclosure thresholds. The mode of acquisition being off-market suggests a negotiated/privately arranged transaction rather than open-market buying.